{
    "clinical_study": {
        "@rank": "152883", 
        "acronym": "EDISON", 
        "brief_summary": {
            "textblock": "To determine the normative ranges of the Insulin-like Growth Factor 1 (IGF-1), Insulin-like\n      growth factor-binding protein 3 (IGFBP-3), Acid-Labile Subunit (ALS) according to age, sex\n      and pubertal stage of a healthy paediatric Spanish population."
        }, 
        "brief_title": "IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "IGF-1 Deficiency", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children of either sex of Caucasian parents\n\n          -  Age: newborns up to and including 18 years of age\n\n          -  Length/height, weight and body mass index (BMI) within the mean +/- 2SD (Standard\n             Deviation) and in accordance with the growth charts of the 2010 Spanish\n             cross-sectional growth study (Carrascosa Lezcano et al 2010)\n\n          -  Signed consent by at least one parent or legal guardian (if subject is \u226418 years) and\n             by subject if \u226512 years\n\n        Exclusion Criteria:\n\n          -  Early or advanced puberty (pubertal signs: between 8 and 9 years old in girls, and\n             between 9 and 10 years old in boys), or delayed puberty (no puberty onset in \u2265 13\n             year-old girls, and in \u2265 14 year-old boys)\n\n          -  Chronic diseases including, but not limited to, endocrinologic diseases, chromosomal\n             diseases, chronic diseases of renal, hepatic and/or cardiac aetiology, and tumour\n             processes\n\n          -  An acute disease during the last two weeks prior to recruitment\n\n          -  Any clinically significant out-of-range lab value\n\n          -  Healthy paediatric volunteers who are under medical treatment (contraception\n             permitted)\n\n          -  A family history of short stature (either parent < P3)\n\n          -  Children born small for gestational age (birth weight, length, or head circumference\n             < P10)\n\n          -  Adopted children or conceived through in vitro fertilization ( IVF )\n\n          -  Subjects who are unwilling or unable in the opinion of the investigator or sponsor to\n             undergo all the study procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Healthy paediatric Spanish population"
            }
        }, 
        "enrollment": {
            "#text": "304", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01676090", 
            "org_study_id": "A-92-52800-020"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 19, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Fundaci\u00f3n Sant Joan de Deu"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitari Vall d\u00b4Hebron"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bilbao", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital de Cruces"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Infantil Universitario Ni\u00f1o Jes\u00fas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital 12 de Octubre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario La Paz"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago de Compostela", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Cl\u00ednico Universitario de Santiago de Compostela"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Nuestra Se\u00f1ora de Valme"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zaragoza", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Miguel Servet"
                }
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "1", 
        "official_title": "An Epidemiologic, Descriptive and Cross-sectional Study of the IGF-1, IGFBP-3 and ALS Normative Ranges in a Healthy Paediatric Spanish Population, Divided Into Chronological Age, Sex and Pubertal Stage", 
        "overall_official": {
            "affiliation": "Ipsen", 
            "last_name": "Elena Hernandez Yuste", 
            "role": "Study Director"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "IGF-1 levels according to age, sex and pubertal stage in healthy paediatric volunteers", 
            "safety_issue": "No", 
            "time_frame": "At the time of participant's single study visit (day 1)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01676090"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "IGFBP-3 levels according to age, sex and pubertal stage in healthy paediatric volunteers", 
                "safety_issue": "No", 
                "time_frame": "At the time of participant's single study visit (day 1)"
            }, 
            {
                "measure": "ALS levels according to age, sex and pubertal stage in healthy paediatric volunteers", 
                "safety_issue": "No", 
                "time_frame": "At the time of participant's single study visit (day 1)"
            }
        ], 
        "source": "Ipsen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ipsen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "December 2013", 
        "why_stopped": "Participant enrolment was lower than expected"
    }
}